GCG and neoplasm: Surprisingly, the glucose levels in all groups showed no differences (Figure S4A, Supporting Information), and glucagon‐treated mice did not show elevated glucose levels, which indicated that the glucagon‐induced synergistic antitumor effect might directly affect endothelial and tumor cells.